| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042449A2 Method for selecting peptide ligands |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2001096364A3 Peptides that stimulate cell survival and axon regeneration |
| 05/30/2002 | WO2001092333A3 Use of adnf for enhancing learning and memory |
| 05/30/2002 | WO2001074858A3 Methods for altering t cell activation |
| 05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
| 05/30/2002 | WO2001042282A9 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/30/2002 | US20020065226 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy |
| 05/30/2002 | US20020065219 Water soluble thiazolyl peptide derivatives |
| 05/30/2002 | US20020065218 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/30/2002 | US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles |
| 05/30/2002 | US20020064770 Detecting preferential receptor associating protein; obtain library, incubate with receptor, detect bound receptor complex, isolate receptor associating protein |
| 05/29/2002 | EP1209931A1 A method for setting up a connection of a mobile station in a cellular telecommunication system |
| 05/29/2002 | EP1209240A1 Novel compound f-15078 |
| 05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
| 05/29/2002 | EP1208846A2 Non-aqueous polar aprotic peptide formulations |
| 05/29/2002 | EP1208379A2 Detection of isomerised epitopes in autoimmune diseases |
| 05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/29/2002 | EP1207909A2 Method for coupling molecules |
| 05/29/2002 | EP1207896A1 Methods and compositions for reducing serum phosphate levels |
| 05/29/2002 | EP1207895A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP0938329B1 Immunogenic tlp composition |
| 05/29/2002 | DE10058319A1 Verfahren zur Selektion von Peptid-Liganden A method for the selection of peptide ligands |
| 05/29/2002 | CN1351610A Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 05/29/2002 | CN1351505A Short-chain peptide dye conjagates used as contrast agents for optical diagnostics |
| 05/28/2002 | US6395873 Method and composition for treating thrombosis |
| 05/28/2002 | US6395491 Coding and storing information on substrate; code biopolymer sequence, attach to substrate, recover information by replication of biopolymer sequence |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | US6395257 Administering indocyanine dye of specific structure to individual for diagnostic imaging or antitumor therapy |
| 05/23/2002 | WO2002040631A2 Dipeptide seryl-histidine and related oligopeptides cleave dna, protein, and a carboxyl ester |
| 05/23/2002 | WO2002040529A2 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 05/23/2002 | WO2002040510A2 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
| 05/23/2002 | WO2002002596A3 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/23/2002 | WO2001088178A3 Peptide substrates for direct measuring of enzyme activities |
| 05/23/2002 | WO2001077687A3 Prion-binding peptidic ligands and methods of using same |
| 05/23/2002 | WO2001038346A3 Short peptides to target epithelial cells |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | CA2771909A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 05/23/2002 | CA2427896A1 Carrier vectors through an epithelium with tight junctions |
| 05/22/2002 | EP1207167A1 Process for the preparation of lh-rh derivatives |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206494A1 Computational design methods for making molecular mimetics |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206482A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 05/22/2002 | EP1206278A2 Peptide mixture and vaccine against a chronic viral infection |
| 05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
| 05/22/2002 | EP0665754B1 Antimicrobial peptides |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
| 05/22/2002 | CN1350002A Deformed streptococcus adherence resisting polypeptide mixture |
| 05/21/2002 | USRE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone |
| 05/21/2002 | US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/21/2002 | US6391856 Method for treatment of allergic reaction using formyl peptide |
| 05/21/2002 | US6391854 Water soluble hypoglycemic agents |
| 05/21/2002 | US6391587 Nucleotide sequences for use in the prevention of microorganismal infections |
| 05/21/2002 | US6391305 Conjugates useful in the treatment of prostate cancer |
| 05/20/2002 | WO2002039947A2 Carrier vectors through an epithelium with tight junctions |
| 05/16/2002 | WO2002038796A2 Methods for determining protease cleavage site motifs |
| 05/16/2002 | WO2002038592A2 Peptides, the production and use thereof for binding immunoglobulins |
| 05/16/2002 | WO2002038591A1 Fap-activated anti-tumor compounds |
| 05/16/2002 | WO2002022658A3 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 05/16/2002 | WO2002007770A3 Polymeric conjugates of antitumor agents |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001068678A3 Peptides that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 05/16/2002 | US20020058788 Deblocking a fluorene methoxy carbonyl in sample; obtain sample, incubate with sulfur compound, recover deblocked compound |
| 05/16/2002 | US20020058785 Novel lipopeptides as antibacterial agents |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058615 Endothelial specific targeting |
| 05/16/2002 | US20020058607 Containing the amino acid sequence (G/S/A/E)-L-F-(F/I/L); each - is a peptide bond, each parenthesis encloses amino acids which are alternatives to one other, and each slash separating the alternative amino acids. |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058247 Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | DE10054687A1 Inhibitoren von Transglutaminasen Inhibitors of transglutaminases |
| 05/15/2002 | EP1204865A1 Use of stabilised synthetic compounds in immunoassay |
| 05/15/2002 | EP1204679A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
| 05/15/2002 | EP1204677A2 Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical |
| 05/15/2002 | EP1204676A1 Streptogramin derivatives, preparation and compositions containing same |
| 05/15/2002 | EP1204675A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
| 05/15/2002 | EP0854700B1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
| 05/15/2002 | CN1348961A Estrogen-growth hormone release peptide conjugated with the function of resisting osteoporosis |
| 05/14/2002 | US6388054 Anti-cancer compounds |
| 05/14/2002 | US6387881 Peptide |
| 05/14/2002 | US6387879 Compounds that bind growth to hormone receptor |
| 05/14/2002 | US6387700 Binding tryptophan-containing peptide to nucleic acid to make complex, then introducing complex to cell so that it is delivered across the cell membrane |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | CA2118757C Aza cyclohexapeptide compounds |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2032907C Hepatitis c assay |
| 05/14/2002 | CA2032499C Polypeptide derivatives |
| 05/10/2002 | WO2002037104A2 Method of purification of neuropeptide containing vesicles from the brain |
| 05/10/2002 | WO2002036798A2 Inhibitors of transglutaminases |
| 05/10/2002 | WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | WO2002036161A2 Novel targeted compositions for diagnostic and therapeutic use |